Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY (Piflufolastat F 18) in Japan
BEDFORD, Mass. and CHICAGO and TOKYO, Sept. 24, 2025 (GLOBE NEWSWIRE) --…
LifeSpan Portfolio Company Remedium Signs Landmark Deal with Eli Lilly
NORWALK, Conn., Sept. 23, 2025 /PRNewswire/ -- Lifespan Vision Ventures is pleased…
OSI Digital Acquires E3 Retail to Deliver Next-Level Retail Solutions
Strategic Acquisition Strengthens OSI's Position as a Global Leader in Unified Commerce CALABASAS,…
Plum Tree Leads the Way in Team-Based Child Therapy and Multidisciplinary Testing
ST. CHARLES, IL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Plum Tree Psychology,…
Blue Point Exits Stax in Sale to Grant Thornton Advisors
Stax team more than triples during four-year Blue Point partnershipCLEVELAND--(BUSINESS WIRE)--Blue Point…
Vocalbeats.AI Strengthens Commitment to AI Advancement as Sponsor of Singapores FutureChina Global Forum 2025
September 22, 2025 05:30 ET Â | Source: Vocalbeats FutureChina Global Forum 2025…
Vantage Secures Triple Win at the 2025 Global Forex Awards – Retail
PORT VILA, Vanuatu, Sept. 19, 2025 /PRNewswire/ -- Vantage Markets, a leading…
CATL and Springer Nature launch journal Watt to connect science and industry
HONG KONG, Sept. 19, 2025 /PRNewswire/ -- 21C Lab, the cutting-edge innovation…
Index Exchange Receives Frost & Sullivan’s 2025 Global New Product Innovation Recognition for Leadership in Supply-Side Platforms
Index Exchange earns acclaim for advancing innovation, transparency, and customer-centric solutions within…
Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being…